Calyxt Inc (CLXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CLXT | AMGN | VRTX | REGN | GILD |
Company | Calyxt Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 6.16 | 333.23 | 497.00 | 1,075.35 | 72.89 |
High | 7.77 | 336.35 | 498.77 | 1,078.71 | 73.32 |
Low | 6.01 | 332.47 | 491.52 | 1,065.62 | 72.02 |
Last | 6.30 | 333.65 | 492.36 | 1,065.64 | 72.50 |
Change | +0.33 | +2.36 | +0.79 | +2.04 | -0.06 |
% Change | +5.53% | +0.71% | +0.16% | +0.19% | -0.08% |
Volume | 254,600 | 380,162 | 263,211 | 67,077 | 997,255 |
20-Day Average Volume | 63,345 | 2,017,988 | 1,102,681 | 414,127 | 6,278,421 |
Previous Close | 5.97 | 331.29 | 491.57 | 1,063.60 | 72.56 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 4.10 | 321.01 | 481.79 | 1,064.32 | 69.79 |
20-Day Raw Stochastic | 69.38% | 89.53% | 84.59% | 60.60% | 73.85% |
20-Day Relative Strength | 75.29% | 68.32% | 66.62% | 57.69% | 63.36% |
Weighted Alpha | +160.70 | +41.84 | +43.45 | +42.18 | -4.48 |
Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
Last Month's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
Performance | |||||
5-Days | |||||
%Chg | +28.05% since 05/23/23 | +1.63% since 07/15/24 | +0.59% since 07/15/24 | -1.22% since 07/15/24 | +2.51% since 07/15/24 |
Low | 4.53 on 05/25/23 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
High | 7.77 on 05/31/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
1-Month | |||||
%Chg | +107.92% since 04/28/23 | +8.88% since 06/21/24 | +5.34% since 06/21/24 | +1.50% since 06/21/24 | +2.72% since 06/21/24 |
Low | 2.64 on 05/01/23 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
High | 7.77 on 05/31/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
3-Month | |||||
%Chg | +49.96% since 02/28/23 | +23.40% since 04/22/24 | +23.46% since 04/22/24 | +18.75% since 04/22/24 | +8.42% since 04/22/24 |
Low | 2.41 on 04/12/23 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
High | 7.77 on 05/31/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
6-Month | |||||
%Chg | +303.33% since 11/28/22 | +8.18% since 01/22/24 | +12.18% since 01/22/24 | +13.37% since 01/22/24 | -7.45% since 01/22/24 |
Low | 1.32 on 12/27/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
High | 7.77 on 05/31/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
Key Statistics | |||||
Market Capitalization, $K | 31,334 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
Shares Outstanding, K | 4,974 | 536,435 | 258,053 | 110,186 | 1,245,853 |
Annual Sales | 160,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
Annual Net Income | -16,890,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
Last Quarter Sales | 40,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
Last Quarter Net Income | -5,390,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
60-Month Beta | 2.04 | 0.58 | 0.39 | 0.13 | 0.18 |
Per-Share Information | |||||
Most Recent Earnings | -1.09 on 05/01/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
Latest Earnings Date | 05/04/23 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |